836 related articles for article (PubMed ID: 18037451)
21. Involvement of serotonin 2A receptors in the analgesic effect of tramadol in mono-arthritic rats.
Xie H; Dong ZQ; Ma F; Bauer WR; Wang X; Wu GC
Brain Res; 2008 May; 1210():76-83. PubMed ID: 18417104
[TBL] [Abstract][Full Text] [Related]
22. Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, O-Desmethyltramadol, via activation of descending serotonergic pathways.
Yanarates O; Dogrul A; Yildirim V; Sahin A; Sizlan A; Seyrek M; Akgül O; Kozak O; Kurt E; Aypar U
Anesthesiology; 2010 Mar; 112(3):696-710. PubMed ID: 20179508
[TBL] [Abstract][Full Text] [Related]
23. [Neurochemical analysis and pharmacological regulation of the corticofugal control of the nociceptive signals in the afferent pathways].
Churiukanov VV
Eksp Klin Farmakol; 2003; 66(2):24-31. PubMed ID: 12962044
[TBL] [Abstract][Full Text] [Related]
24. Evidence for a selective role of the delta-opioid agonist [8R-(4bS*,8aalpha,8abeta, 12bbeta)]7,10-Dimethyl-1-methoxy-11-(2-methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexahydro-(9H)-4,8-methanobenzofuro[3,2-e]pyrrolo[2,3-g]isoquinoline hydrochloride (SB-235863) in blocking hyperalgesia associated with inflammatory and neuropathic pain responses.
Petrillo P; Angelici O; Bingham S; Ficalora G; Garnier M; Zaratin PF; Petrone G; Pozzi O; Sbacchi M; Stean TO; Upton N; Dondio GM; Scheideler MA
J Pharmacol Exp Ther; 2003 Dec; 307(3):1079-89. PubMed ID: 14551288
[TBL] [Abstract][Full Text] [Related]
25. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats.
Honore P; Wismer CT; Mikusa J; Zhu CZ; Zhong C; Gauvin DM; Gomtsyan A; El Kouhen R; Lee CH; Marsh K; Sullivan JP; Faltynek CR; Jarvis MF
J Pharmacol Exp Ther; 2005 Jul; 314(1):410-21. PubMed ID: 15837818
[TBL] [Abstract][Full Text] [Related]
26. [The opioid tramadol demonstrates excitatory properties of non-opioid character--a preclinical study using alfentanil as a comparison].
Freye E; Latasch L; Von Bredow G; Neruda B
Schmerz; 1998 Feb; 12(1):19-24. PubMed ID: 12799988
[TBL] [Abstract][Full Text] [Related]
27. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
[TBL] [Abstract][Full Text] [Related]
28. Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity.
DeHaven-Hudkins DL; Burgos LC; Cassel JA; Daubert JD; DeHaven RN; Mansson E; Nagasaka H; Yu G; Yaksh T
J Pharmacol Exp Ther; 1999 Apr; 289(1):494-502. PubMed ID: 10087042
[TBL] [Abstract][Full Text] [Related]
29. Behavioural effects of the novel AMPA/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain.
Blackburn-Munro G; Bomholt SF; Erichsen HK
Neuropharmacology; 2004 Sep; 47(3):351-62. PubMed ID: 15275824
[TBL] [Abstract][Full Text] [Related]
30. Evidence of self-synergism in the antinociceptive effect of tramadol in rats.
de Pozos-Guillén AJ; Aguirre-Bañuelos P; Arellano-Guerrero A; Hoyo-Vadillo C; Pérez-Urizar J
Proc West Pharmacol Soc; 2004; 47():117-9. PubMed ID: 15633629
[TBL] [Abstract][Full Text] [Related]
31. Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats.
Arreola-Espino R; Urquiza-Marín H; Ambriz-Tututi M; Araiza-Saldaña CI; Caram-Salas NL; Rocha-González HI; Mixcoatl-Zecuatl T; Granados-Soto V
Eur J Pharmacol; 2007 Dec; 577(1-3):203-10. PubMed ID: 17920585
[TBL] [Abstract][Full Text] [Related]
32. Studies with ketamine and alfentanil following Freund's complete adjuvant-induced inflammation in rats.
Edwards SR; Mather LE; Smith MT
Clin Exp Pharmacol Physiol; 2007; 34(5-6):414-20. PubMed ID: 17439409
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterisation of acid-induced muscle allodynia in rats.
Nielsen AN; Mathiesen C; Blackburn-Munro G
Eur J Pharmacol; 2004 Mar; 487(1-3):93-103. PubMed ID: 15033380
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of selective NK(1) receptor antagonist CI-1021 in animal models of inflammatory and neuropathic pain.
Gonzalez MI; Field MJ; Hughes J; Singh L
J Pharmacol Exp Ther; 2000 Aug; 294(2):444-50. PubMed ID: 10900217
[TBL] [Abstract][Full Text] [Related]
35. Nociceptive sensitivity and opioid antinociception and antihyperalgesia in Freund's adjuvant-induced arthritic male and female rats.
Cook CD; Nickerson MD
J Pharmacol Exp Ther; 2005 Apr; 313(1):449-59. PubMed ID: 15608071
[TBL] [Abstract][Full Text] [Related]
36. Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain.
Bomholt SF; Mikkelsen JD; Blackburn-Munro G
Neuropharmacology; 2005 Feb; 48(2):252-63. PubMed ID: 15695164
[TBL] [Abstract][Full Text] [Related]
37. Stimulation of mu and delta opioid receptors induces hyperalgesia while stimulation of kappa receptors induces antinociception in the hot plate test in the naked mole-rat (Heterocephalus glaber).
Towett PK; Kanui TI; Juma FD
Brain Res Bull; 2006 Dec; 71(1-3):60-8. PubMed ID: 17113929
[TBL] [Abstract][Full Text] [Related]
38. Isobolographic analysis of the dual-site synergism in the antinociceptive response of tramadol in the formalin test in rats.
Pozos-Guillén AJ; Aguirre-Bañuelos P; Arellano-Guerrero A; Castañeda-Hernández G; Hoyo-Vadillo C; Pérez-Urizar J
Life Sci; 2006 Nov; 79(24):2275-82. PubMed ID: 16934842
[TBL] [Abstract][Full Text] [Related]
39. Antihyperalgesic effects of delta opioid agonists in a rat model of chronic inflammation.
Fraser GL; Gaudreau GA; Clarke PB; Ménard DP; Perkins MN
Br J Pharmacol; 2000 Apr; 129(8):1668-72. PubMed ID: 10780972
[TBL] [Abstract][Full Text] [Related]
40. The antinociceptive effects of centrally administered CDP-choline on acute pain models in rats: the involvement of cholinergic system.
Hamurtekin E; Gurun MS
Brain Res; 2006 Oct; 1117(1):92-100. PubMed ID: 16942753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
